Submitted by Office of U.S. Senator Jim Banks
On Monday, April 20, Senator Jim Banks (R-Ind.) sent a letter to the Federal Trade Commission Chairman, Andrew Ferguson, urging the Commission to investigate abortion drug companies for allegedly pushing misleading safety claims about their products and engaging in deceptive trade practices that could endanger women’s health.
Click here to read the full letter.
Be the first to comment on "Banks calls on FTC to probe abortion drug companies over alleged deceptive safety claims"